JP2025011178A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2025011178A5 JP2025011178A5 JP2024174919A JP2024174919A JP2025011178A5 JP 2025011178 A5 JP2025011178 A5 JP 2025011178A5 JP 2024174919 A JP2024174919 A JP 2024174919A JP 2024174919 A JP2024174919 A JP 2024174919A JP 2025011178 A5 JP2025011178 A5 JP 2025011178A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- amino acid
- acid sequence
- antibody
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EPPCT/EP2013/002272 | 2013-07-31 | ||
| PCT/EP2013/002272 WO2015014376A1 (en) | 2013-07-31 | 2013-07-31 | Diagnosis and therapy of cancer involving cancer stem cells |
| JP2020024949A JP7136822B2 (ja) | 2013-07-31 | 2020-02-18 | 癌幹細胞を含む癌の診断および治療法 |
| JP2022139001A JP7611196B2 (ja) | 2013-07-31 | 2022-09-01 | 癌幹細胞を含む癌の診断および治療法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022139001A Division JP7611196B2 (ja) | 2013-07-31 | 2022-09-01 | 癌幹細胞を含む癌の診断および治療法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025011178A JP2025011178A (ja) | 2025-01-23 |
| JP2025011178A5 true JP2025011178A5 (enExample) | 2025-03-25 |
Family
ID=48914215
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016530504A Pending JP2016533738A (ja) | 2013-07-31 | 2014-07-30 | 癌幹細胞を含む癌の診断および治療法 |
| JP2019020349A Active JP6865778B2 (ja) | 2013-07-31 | 2019-02-07 | 癌幹細胞を含む癌の診断および治療法 |
| JP2020024949A Active JP7136822B2 (ja) | 2013-07-31 | 2020-02-18 | 癌幹細胞を含む癌の診断および治療法 |
| JP2022139001A Active JP7611196B2 (ja) | 2013-07-31 | 2022-09-01 | 癌幹細胞を含む癌の診断および治療法 |
| JP2024174919A Pending JP2025011178A (ja) | 2013-07-31 | 2024-10-04 | 癌幹細胞を含む癌の診断および治療法 |
Family Applications Before (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016530504A Pending JP2016533738A (ja) | 2013-07-31 | 2014-07-30 | 癌幹細胞を含む癌の診断および治療法 |
| JP2019020349A Active JP6865778B2 (ja) | 2013-07-31 | 2019-02-07 | 癌幹細胞を含む癌の診断および治療法 |
| JP2020024949A Active JP7136822B2 (ja) | 2013-07-31 | 2020-02-18 | 癌幹細胞を含む癌の診断および治療法 |
| JP2022139001A Active JP7611196B2 (ja) | 2013-07-31 | 2022-09-01 | 癌幹細胞を含む癌の診断および治療法 |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US10604568B2 (enExample) |
| JP (5) | JP2016533738A (enExample) |
| KR (4) | KR102483410B1 (enExample) |
| CN (3) | CN113406327B (enExample) |
| AR (1) | AR097178A1 (enExample) |
| AU (3) | AU2014298505B2 (enExample) |
| BR (1) | BR112016002000A2 (enExample) |
| CA (1) | CA2919570A1 (enExample) |
| DK (1) | DK3027208T3 (enExample) |
| ES (2) | ES3041948T3 (enExample) |
| HU (1) | HUE050622T2 (enExample) |
| IL (4) | IL308523B2 (enExample) |
| MX (2) | MX385872B (enExample) |
| NZ (1) | NZ716473A (enExample) |
| PT (1) | PT3027208T (enExample) |
| RU (2) | RU2749867C2 (enExample) |
| SG (2) | SG11201600722PA (enExample) |
| UA (1) | UA123428C2 (enExample) |
| WO (2) | WO2015014376A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010094499A1 (en) | 2009-02-20 | 2010-08-26 | Ganymed Pharmaceuticals Ag | Methods and compositions for diagnosis and treatment of cancer |
| EP2404936A1 (en) | 2010-07-06 | 2012-01-11 | Ganymed Pharmaceuticals AG | Cancer therapy using CLDN6 target-directed antibodies in vivo |
| HUE028603T2 (en) | 2011-05-13 | 2016-12-28 | Ganymed Pharmaceuticals Ag | Antibodies for treatment of cancer expressing claudin 6 |
| US9758591B2 (en) | 2012-08-24 | 2017-09-12 | The Regents Of The University Of California | Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis |
| WO2015014376A1 (en) * | 2013-07-31 | 2015-02-05 | Biontech Ag | Diagnosis and therapy of cancer involving cancer stem cells |
| PE20160870A1 (es) | 2013-11-06 | 2016-09-09 | Abbvie Stemcentrx Llc | Anticuerpos anti-claudina novedosos y metodos de uso |
| RU2664749C1 (ru) * | 2015-03-31 | 2018-08-22 | Мицубиси Хитачи Пауэр Системз, Лтд. | Горелка для сжигания и котел |
| WO2016165762A1 (en) * | 2015-04-15 | 2016-10-20 | Ganymed Pharmaceuticals Ag | Drug conjugates comprising antibodies against claudin 18.2 |
| US20180371550A1 (en) * | 2015-07-08 | 2018-12-27 | Children's Hospital Medical Center | Loss of transcriptional fidelity leads to immunotherapy resistance in cancers |
| MX2018016330A (es) | 2016-06-27 | 2020-02-17 | Univ California | Combinaciones para tratamiento del cáncer. |
| KR102726248B1 (ko) | 2016-07-07 | 2024-11-05 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 항체-애쥬번트 접합체 |
| CN111093701A (zh) * | 2017-06-15 | 2020-05-01 | 财团法人生物技术开发中心 | 含有抗globo h抗体的抗体药物偶联物及其用途 |
| WO2019048040A1 (en) * | 2017-09-06 | 2019-03-14 | Ganymed Pharmaceuticals Gmbh | ANTIBODIES USEFUL IN THE DIAGNOSIS OF CANCER |
| EP3681993A1 (en) * | 2017-09-13 | 2020-07-22 | BioNTech RNA Pharmaceuticals GmbH | Rna replicon for reprogramming somatic cells |
| DK3826667T3 (da) * | 2017-09-18 | 2024-07-22 | Univ California | Claudin6-antistoffer og fremgangsmåder til behandling af kræft |
| CN117003875A (zh) | 2017-09-29 | 2023-11-07 | 第一三共株式会社 | 抗体或其功能性片段、多核苷酸、表达载体、宿主细胞、糖链重构抗体、药物组合物、应用 |
| EP3838291A4 (en) * | 2018-08-13 | 2022-05-11 | Cancerstem Tech Inc. | CANCER STEM CELL MARKERS AND ANTI-CANCER STEM CELL PHARMACEUTICALS |
| KR20210128443A (ko) | 2019-02-15 | 2021-10-26 | 인테그럴 몰큘러 인코포레이티드 | 클라우딘 6 항체 및 이의 용도 |
| CA3130794A1 (en) | 2019-03-15 | 2020-09-24 | Bolt Biotherapeutics, Inc. | Immunoconjugates targeting her2 |
| DK3941946T3 (da) * | 2019-03-20 | 2025-03-24 | Univ California | Claudin-6-antistoffer og lægemiddelkonjugater |
| WO2021006328A1 (en) | 2019-07-10 | 2021-01-14 | Chugai Seiyaku Kabushiki Kaisha | Claudin-6 binding molecules and uses thereof |
| CN111087465B (zh) * | 2019-12-24 | 2020-12-08 | 广州医科大学 | 一种针对密蛋白6的抗体偶联药物及应用 |
| CN113832226B (zh) * | 2020-06-24 | 2023-06-30 | 广州医科大学附属第五医院 | 研究gnl3与肝癌发展的相关性的方法及gnl3作为肝肿瘤干细胞、肝癌标志物的用途 |
| CN116917009A (zh) | 2021-02-19 | 2023-10-20 | 美国迈胜医疗系统有限公司 | 用于粒子治疗系统的机架 |
| KR20250114330A (ko) | 2022-11-30 | 2025-07-29 | 인테그럴 몰큘러 인코포레이티드 | 클라우딘 6을 표적하는 항체 및 이의 이중특이적 형식 |
| WO2024165057A1 (en) * | 2023-02-07 | 2024-08-15 | LaNova Medicines Limited | Antibodies and antibody-drug conjugates targeting claudin 6 |
| AU2024274880A1 (en) | 2023-05-25 | 2026-01-15 | The Regents Of The University Of California | Methods of treating cancer |
Family Cites Families (77)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| AU600575B2 (en) | 1987-03-18 | 1990-08-16 | Sb2, Inc. | Altered antibodies |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| GB8809129D0 (en) | 1988-04-18 | 1988-05-18 | Celltech Ltd | Recombinant dna methods vectors and host cells |
| US6255458B1 (en) | 1990-08-29 | 2001-07-03 | Genpharm International | High affinity human antibodies and human antibodies against digoxin |
| GB9019812D0 (en) | 1990-09-11 | 1990-10-24 | Scotgen Ltd | Novel antibodies for treatment and prevention of infection in animals and man |
| US5830755A (en) | 1995-03-27 | 1998-11-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | T-cell receptors and their use in therapeutic and diagnostic methods |
| US6121022A (en) | 1995-04-14 | 2000-09-19 | Genentech, Inc. | Altered polypeptides with increased half-life |
| US5677139A (en) | 1995-04-21 | 1997-10-14 | President And Fellows Of Harvard College | In vitro differentiation of CD34+ progenitor cells into T lymphocytes |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| WO2000073348A2 (en) | 1999-06-02 | 2000-12-07 | Genentech, Inc. | Methods and compositions for inhibiting neoplastic cell growth |
| WO2002008284A2 (en) | 2000-07-20 | 2002-01-31 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| US6277375B1 (en) | 1997-03-03 | 2001-08-21 | Board Of Regents, The University Of Texas System | Immunoglobulin-like domains with increased half-lives |
| WO2000012708A2 (en) | 1998-09-01 | 2000-03-09 | Genentech, Inc. | Further pro polypeptides and sequences thereof |
| WO2000078961A1 (en) | 1999-06-23 | 2000-12-28 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US5928631A (en) | 1997-06-09 | 1999-07-27 | The Procter & Gamble Company | Methods for controlling environmental odors on the body using compositions comprising uncomplexed cyclodextrins |
| US20020127584A1 (en) | 1997-09-18 | 2002-09-12 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| US5932445A (en) | 1997-11-07 | 1999-08-03 | Incyte Pharmaceuticals, Inc. | Signal peptide-containing proteins |
| US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| US6830894B1 (en) | 1998-11-03 | 2004-12-14 | Adherex Technologies, Inc. | Compounds and methods for modulating claudin-mediated functions |
| JP2002532083A (ja) | 1998-12-17 | 2002-10-02 | ヒューマン ジノーム サイエンシーズ， インコーポレイテッド | ４７個のヒト分泌タンパク質 |
| JP2002536995A (ja) | 1999-02-22 | 2002-11-05 | インサイト・ファーマスーティカルズ・インコーポレイテッド | 結腸の疾患に関連する遺伝子 |
| EP1514933A1 (en) | 1999-07-08 | 2005-03-16 | Research Association for Biotechnology | Secretory protein or membrane protein |
| WO2001053312A1 (en) | 1999-12-23 | 2001-07-26 | Hyseq, Inc. | Novel nucleic acids and polypeptides |
| WO2001051513A2 (en) | 2000-01-14 | 2001-07-19 | Corixa Corporation | Ovarian tumor-associated sequences |
| PT1309726E (pt) | 2000-03-30 | 2010-03-08 | Whitehead Biomedical Inst | Mediadores de interferência por rna específicos de sequência de rna |
| AU6531101A (en) | 2000-06-02 | 2001-12-17 | Genentech Inc | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| EP1309620A2 (en) | 2000-06-23 | 2003-05-14 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis |
| JP2004514420A (ja) | 2000-07-20 | 2004-05-20 | ジェネンテック・インコーポレーテッド | 分泌及び膜貫通ポリペプチドとそれをコードする核酸 |
| US20030100713A1 (en) | 2000-07-25 | 2003-05-29 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| WO2002012437A2 (en) | 2000-08-03 | 2002-02-14 | Schooten Wim Van | Production of humanized antibodies in transgenic animals |
| JP3523245B1 (ja) | 2000-11-30 | 2004-04-26 | メダレックス，インコーポレーテッド | ヒト抗体作製用トランスジェニック染色体導入齧歯動物 |
| US7754208B2 (en) | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
| US20030133939A1 (en) | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| EP1992643A3 (en) | 2001-06-20 | 2008-12-10 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| CA2379661A1 (en) | 2002-03-28 | 2003-09-28 | Kursad Turksen | Paracellular drug delivery system |
| KR20040101502A (ko) | 2002-04-16 | 2004-12-02 | 제넨테크, 인크. | 종양의 진단 및 치료 방법 및 이를 위한 조성물 |
| US20070207142A1 (en) * | 2002-05-08 | 2007-09-06 | Genentech, Inc. | Compositions and methods for the treatment of tumor of hematopoietic origin |
| EP1594447A2 (en) | 2002-10-02 | 2005-11-16 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| PL216630B1 (pl) | 2002-10-17 | 2014-04-30 | Genmab As | Izolowane ludzkie przeciwciało monoklonalne wiążące ludzki CD20, związane z tym przeciwciałem transfektoma, komórka gospodarza, transgeniczne zwierzę lub roślina, kompozycja, immunokoniugat, cząsteczka bispecyficzna, wektor ekspresyjny, kompozycja farmaceutyczna, zastosowanie medyczne, zestaw oraz przeciwciało antyidiotypowe i jego zastosowanie |
| WO2004060270A2 (en) | 2002-10-18 | 2004-07-22 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
| AT500651B9 (de) | 2003-05-27 | 2010-04-15 | Altropus Gmbh | Aktiv immunisierender antikörper |
| BRPI0410875A (pt) | 2003-05-30 | 2006-07-04 | Centocor Inc | método de inibição do crescimento de tumor com anticorpos de fator antitecido |
| EP2003196A3 (en) * | 2003-06-09 | 2009-01-07 | The Regents of the University of Michigan | Compositions and methods for treating and diagnosing cancer |
| WO2006033664A1 (en) | 2004-03-08 | 2006-03-30 | Avalon Pharmaceuticals | Determining cancer-linked genes and therapeutic targets using molecular cytogenetic methods |
| US7431927B2 (en) | 2005-03-24 | 2008-10-07 | Epitomics, Inc. | TNFα-neutralizing antibodies |
| DE102005025041A1 (de) | 2005-05-30 | 2006-12-07 | Bell Flavors & Fragrances Duft Und Aroma Gmbh | Mittel zur Anwendung in Spülmaschinen sowie Vorrichtung für dessen dosierte Einbringung während der Spül- und Trocknungsphasen |
| EP1790664A1 (en) | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| EP2089425B1 (en) * | 2006-11-10 | 2011-08-17 | CovX Technologies Ireland Limited | Anti-angiogenic compounds |
| EP2138576A4 (en) | 2007-03-16 | 2011-02-23 | Kyowa Hakko Kirin Co Ltd | ANTI-CLAUDIN-4 ANTIBODY |
| EP1997832A1 (en) | 2007-05-29 | 2008-12-03 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against Claudin-18 for treatment of cancer |
| WO2009025759A1 (en) | 2007-08-17 | 2009-02-26 | Progenics Pharmaceuticals (Nevada), Inc. | Tight junction proteins associated with infection and entry of hepatitis c virus (hcv), methods and uses thereof |
| WO2009028663A1 (ja) | 2007-08-30 | 2009-03-05 | Kyowa Hakko Kirin Co., Ltd. | 抗Claudin-3抗体 |
| EP2060583A1 (en) | 2007-10-23 | 2009-05-20 | Ganymed Pharmaceuticals AG | Identification of tumor-associated markers for diagnosis and therapy |
| RU2010133547A (ru) * | 2008-01-11 | 2012-02-20 | Дзе Юниверсити Оф Токио (Jp) | Анти-cldn антитела |
| US20110044894A1 (en) * | 2008-03-26 | 2011-02-24 | Cellerant Therapeutics, Inc. | Immunoglobulin and/or Toll-Like Receptor Proteins Associated with Myelogenous Haematological Proliferative Disorders and Uses Thereof |
| CA2721072A1 (en) | 2008-04-11 | 2009-10-15 | Bionovo, Inc. | Anticancer methods employing extracts of gleditsia sinensis lam |
| EP2352764B1 (en) | 2008-10-14 | 2018-03-28 | Ablynx N.V. | AMINO ACID SEQUENCES TARGETING HUMAN CD4 and CXCR4, CCR5, TLR4, ALPHAV INTEGRIN, BETA3-INTEGRIN,BETA1-INTEGRIN, HUMAN ALPHA2-INTEGRIN, CD81, SR-BI, CLAUDIN-1, CLAUDIN-6 AND/OR CLAUDIN-9, RESPECTIVELY, AND NEUTRALIZING VIRAL ENTRY |
| DE102009026966A1 (de) | 2008-12-18 | 2010-07-01 | Robert Bosch Gmbh | Betrieb eines Bremskraftverstärkers als Pedalsimulator |
| JP2010178650A (ja) | 2009-02-04 | 2010-08-19 | Univ Of Tokyo | 固形癌の再発予測のための試験方法および再発予防剤 |
| WO2010094499A1 (en) | 2009-02-20 | 2010-08-26 | Ganymed Pharmaceuticals Ag | Methods and compositions for diagnosis and treatment of cancer |
| EP2221063A1 (en) | 2009-02-20 | 2010-08-25 | Ganymed Pharmaceuticals AG | Methods and compositions for diagnosis and treatment of cancer |
| EP3305813B1 (en) * | 2009-11-11 | 2020-01-15 | Ganymed Pharmaceuticals GmbH | Antibodies specific for claudin 6 (cldn6) |
| EP2322555A1 (en) | 2009-11-11 | 2011-05-18 | Ganymed Pharmaceuticals AG | Antibodies specific for claudin 6 (CLDN6) |
| WO2011105551A1 (ja) | 2010-02-26 | 2011-09-01 | 国立大学法人大阪大学 | 癌幹細胞の検出方法、及び癌の治療剤または再発予防剤 |
| JP2011213612A (ja) * | 2010-03-31 | 2011-10-27 | Kyowa Hakko Kirin Co Ltd | 癌幹細胞及び／または癌前駆細胞の減少剤 |
| EP2404936A1 (en) * | 2010-07-06 | 2012-01-11 | Ganymed Pharmaceuticals AG | Cancer therapy using CLDN6 target-directed antibodies in vivo |
| HUE028603T2 (en) | 2011-05-13 | 2016-12-28 | Ganymed Pharmaceuticals Ag | Antibodies for treatment of cancer expressing claudin 6 |
| EP2749641B1 (en) | 2011-09-07 | 2021-06-02 | Chugai Seiyaku Kabushiki Kaisha | Cancer stem cell isolation |
| EP2605017A1 (de) | 2011-12-16 | 2013-06-19 | Protagen AG | Markersequenzen für gynäkologisches Malignom und deren Verwendung |
| KR101242726B1 (ko) | 2012-01-26 | 2013-03-13 | 한국과학기술원 | 종양줄기세포 특성 암의 진단 및 치료제 |
| MX366178B (es) | 2012-07-19 | 2019-07-01 | Amgen Inc | Proteinas de btnl3, acidos nucleicos, y anticuerpos y los usos de los mismos. |
| WO2014075697A1 (en) * | 2012-11-13 | 2014-05-22 | Biontech Ag | Agents for treatment of claudin expressing cancer diseases |
| NZ746691A (en) * | 2012-11-13 | 2020-08-28 | Astellas Pharma Inc | Agents for treatment of claudin expressing cancer diseases |
| HUE055044T2 (hu) * | 2013-03-14 | 2021-10-28 | Translate Bio Inc | MRNS-kódolt ellenanyagok bejuttatására szolgáló eljárások és készítmények |
| WO2015014376A1 (en) * | 2013-07-31 | 2015-02-05 | Biontech Ag | Diagnosis and therapy of cancer involving cancer stem cells |
-
2013
- 2013-07-31 WO PCT/EP2013/002272 patent/WO2015014376A1/en not_active Ceased
-
2014
- 2014-07-29 IL IL308523A patent/IL308523B2/en unknown
- 2014-07-30 IL IL310824A patent/IL310824A/en unknown
- 2014-07-30 MX MX2016001186A patent/MX385872B/es unknown
- 2014-07-30 CN CN202110621737.5A patent/CN113406327B/zh active Active
- 2014-07-30 CN CN201480042769.8A patent/CN105407922B/zh active Active
- 2014-07-30 SG SG11201600722PA patent/SG11201600722PA/en unknown
- 2014-07-30 DK DK14750331.2T patent/DK3027208T3/da active
- 2014-07-30 KR KR1020217031149A patent/KR102483410B1/ko active Active
- 2014-07-30 KR KR1020167005323A patent/KR102308813B1/ko active Active
- 2014-07-30 PT PT147503312T patent/PT3027208T/pt unknown
- 2014-07-30 KR KR1020247014359A patent/KR102867808B1/ko active Active
- 2014-07-30 BR BR112016002000A patent/BR112016002000A2/pt not_active Application Discontinuation
- 2014-07-30 AU AU2014298505A patent/AU2014298505B2/en active Active
- 2014-07-30 IL IL293880A patent/IL293880B2/en unknown
- 2014-07-30 RU RU2016107005A patent/RU2749867C2/ru active
- 2014-07-30 NZ NZ716473A patent/NZ716473A/en unknown
- 2014-07-30 JP JP2016530504A patent/JP2016533738A/ja active Pending
- 2014-07-30 US US14/904,011 patent/US10604568B2/en active Active
- 2014-07-30 ES ES20180951T patent/ES3041948T3/es active Active
- 2014-07-30 CN CN202110630292.7A patent/CN113252898A/zh active Pending
- 2014-07-30 SG SG10201800834RA patent/SG10201800834RA/en unknown
- 2014-07-30 KR KR1020227045732A patent/KR102663127B1/ko active Active
- 2014-07-30 ES ES14750331T patent/ES2807181T3/es active Active
- 2014-07-30 RU RU2020123616A patent/RU2020123616A/ru unknown
- 2014-07-30 IL IL243408A patent/IL243408B/en unknown
- 2014-07-30 UA UAA201601865A patent/UA123428C2/uk unknown
- 2014-07-30 WO PCT/EP2014/066330 patent/WO2015014870A1/en not_active Ceased
- 2014-07-30 HU HUE14750331A patent/HUE050622T2/hu unknown
- 2014-07-30 CA CA2919570A patent/CA2919570A1/en active Pending
- 2014-07-31 AR ARP140102879A patent/AR097178A1/es active IP Right Grant
-
2016
- 2016-01-27 MX MX2021010672A patent/MX2021010672A/es unknown
-
2019
- 2019-02-07 JP JP2019020349A patent/JP6865778B2/ja active Active
-
2020
- 2020-02-18 JP JP2020024949A patent/JP7136822B2/ja active Active
- 2020-02-19 US US16/795,468 patent/US11795218B2/en active Active
- 2020-02-24 AU AU2020201331A patent/AU2020201331B2/en active Active
-
2022
- 2022-07-19 AU AU2022206711A patent/AU2022206711B2/en active Active
- 2022-09-01 JP JP2022139001A patent/JP7611196B2/ja active Active
-
2023
- 2023-06-22 US US18/339,837 patent/US20240059772A1/en active Pending
-
2024
- 2024-10-04 JP JP2024174919A patent/JP2025011178A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025011178A5 (enExample) | ||
| JP2022101693A5 (enExample) | ||
| ME02371B (me) | Sastojci i postupci za dijagnstikovanje i tretman raka | |
| JP2020516240A5 (enExample) | ||
| JP2019533719A5 (enExample) | ||
| RU2019138067A (ru) | Биспецифическое антитело против ox40 и ctla-4 | |
| JPWO2019215728A5 (enExample) | ||
| JP2018518540A5 (enExample) | ||
| RU2017116020A (ru) | Комбинированная терапия биспецифичными антителами, специфичными к fap и dr5, и химиотерапевтические агенты | |
| JP2017503480A5 (enExample) | ||
| JPWO2020011964A5 (enExample) | ||
| JPWO2019129221A5 (enExample) | ||
| FI3941946T3 (fi) | Klaudiini-6-vasta-aineita ja klaudiini-6-vasta-ainelääkekonjugaatteja | |
| JP2013527762A5 (enExample) | ||
| JP2023089245A5 (enExample) | ||
| JP2024116283A5 (enExample) | ||
| JP2024016024A5 (enExample) | ||
| JP2020528936A5 (enExample) | ||
| JPWO2023028653A5 (enExample) | ||
| JPWO2019140229A5 (enExample) | ||
| JPWO2021190622A5 (enExample) | ||
| JPWO2020023548A5 (enExample) | ||
| JP2020527594A5 (enExample) | ||
| JPWO2023161943A5 (enExample) | ||
| JPWO2023051683A5 (enExample) |